Therapy-induced methionine competition in bladder cancer: MAT2A-SAM axis remodeling as a metabolic immune checkpoint

Chengyuan Zhang, Zhe Zhang, Jianbin Bi

Open source

DOI
10.3389/fimmu.2026.1965813
Published
2026-10-22
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1965813,
  title = {Therapy-induced methionine competition in bladder cancer: MAT2A-SAM axis remodeling as a metabolic immune checkpoint},
  author = {Chengyuan Zhang and Zhe Zhang and Jianbin Bi},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1965813},
  url = {https://doi.org/10.3389/fimmu.2026.1965813}
}

RIS

TY  - JOUR
TI  - Therapy-induced methionine competition in bladder cancer: MAT2A-SAM axis remodeling as a metabolic immune checkpoint
AU  - Chengyuan Zhang
AU  - Zhe Zhang
AU  - Jianbin Bi
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1965813
UR  - https://doi.org/10.3389/fimmu.2026.1965813
ER  - 

APA

Zhang, C., Zhang, Z., & Bi, J. (2026). Therapy-induced methionine competition in bladder cancer: MAT2A-SAM axis remodeling as a metabolic immune checkpoint. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1965813

Source records